MetaCap

Electromed Inc. (ELMD)

NYSE: ELMDHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

22.98-0.28 (-1.20%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ELMD stock chart

Technical analysis

Key statistics

All statistics
Market cap
$187.84M
52-week range
22.67 – 47.40
Day range
22.89 – 23.24
Volume / Avg
80.79K / 83.59K
Beta
—

52-week range

$22.67$47.40

ELMD stock today

Shares of Electromed (ELMD) finished lower on Nov 20 at $22.98, a drop of 1.20% or $0.28 per share, versus the S&P 500's 3.70% decline. At this level, ELMD sits near the bottom of its 52-week range of $22.67 to $47.40: 51.5% below the high, set on Jul 7, 2026 and 1.4% above the low. ELMD is down 21.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 11.3%.

Electromed trades at 16.7x its trailing twelve-month earnings per share of $1.38. Its forward P/E of 37.7x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Electromed

Company profile

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. James L. Cunniff
Headquarters
New Prague, MN
Employees
195
IPO year
2011

Financial highlights

Full financials

In fiscal 2026, Electromed generated $73.8 million in revenue, up 15.3% from fiscal 2025, its 13th consecutive year of revenue growth. Net income was $11.3 million (+49.9% year over year), for a net margin of 15.3% versus a median of 6.6% in the prior 5 years. Gross margin was 78.5% (up from 78.1%) and operating margin 18.8%.

Electromed annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$73.78M$64.00M$54.72M$48.07M$41.66M
Growth+15.28%+16.97%+13.83%+15.38%+16.51%
Net income$11.30M$7.54M$5.15M$3.17M$2.31M
EPS (diluted)$1.30$0.85$0.58$0.36$0.26

Analyst forecast

Forecast

Consensus (2 analysts)

strong_buy

Avg. price target

$48.50+111.05%

  • Strong buy 0
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $47.00High $50.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 10, 2026
EPS actual vs est.
$0.32 vs —

Electromed peers

Health Care sector
ELMD peer companies
CompanyPrice% ChgMarket capCompare
FOCLEDAP TMS S.A. ADR2.61-7.45%$123.25Mvs ELMD
VANIVivani Medical Inc.1.14+4.59%$102.83Mvs ELMD
STXSStereotaxis Inc.0.9422-6.71%$95.03Mvs ELMD
HSDTSolana Company Class A1.49-10.24%$93.70Mvs ELMD
NRXSNeuraxis Inc.4.22-6.22%$59.90Mvs ELMD
HYPRHyperfine Inc. Class A0.5465+4.27%$57.96Mvs ELMD
CVCapsoVision Inc.6.11-3.17%$327.56Mvs ELMD
OMOutset Medical Inc.2.81-3.44%$53.03Mvs ELMD

Indexes, lists and sector

Electromed stock FAQ

What is Electromed's stock price today?

ELMD last traded at $22.98 as of Nov 20, 4:00 PM EST, down 1.20% on the day. Prices are delayed at least 15 minutes.

What is ELMD's P/E ratio?

ELMD trades at a trailing P/E ratio of 16.65 and a forward P/E of 37.67.

Who is Electromed's CEO?

Mr. James L. Cunniff is the chief executive officer of Electromed Inc., which has about 195 employees.

What is the ELMD 52-week high?

The 52-week high for ELMD is $47.40 and the 52-week low is $22.67. The stock is currently 51.5% below its high.

Compare ELMD